Martha M. Eibl

5.8k total citations
175 papers, 3.5k citations indexed

About

Martha M. Eibl is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Martha M. Eibl has authored 175 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Immunology, 32 papers in Epidemiology and 28 papers in Infectious Diseases. Recurrent topics in Martha M. Eibl's work include Immune Cell Function and Interaction (49 papers), Immunodeficiency and Autoimmune Disorders (47 papers) and T-cell and B-cell Immunology (21 papers). Martha M. Eibl is often cited by papers focused on Immune Cell Function and Interaction (49 papers), Immunodeficiency and Autoimmune Disorders (47 papers) and T-cell and B-cell Immunology (21 papers). Martha M. Eibl collaborates with scholars based in Austria, United States and Germany. Martha M. Eibl's co-authors include Hermann M. Wolf, Thomas R. Kreil, J W Mannhalter, Josef W. Mannhalter, Rafi Ahmad, Gerhard J. Zlabinger, Helen Chapel, Werner Engl, G Spickett and Janne Björkander and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Martha M. Eibl

170 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha M. Eibl Austria 31 1.8k 686 642 563 464 175 3.5k
Becky Adkins United States 36 2.6k 1.4× 843 1.2× 435 0.7× 501 0.9× 816 1.8× 77 4.6k
Steve Kohl United States 34 1.5k 0.8× 1.7k 2.5× 663 1.0× 572 1.0× 359 0.8× 141 3.9k
E. Richard Stiehm United States 25 809 0.4× 629 0.9× 427 0.7× 345 0.6× 303 0.7× 79 2.9k
Raffaele Badolato Italy 43 3.2k 1.8× 857 1.2× 724 1.1× 865 1.5× 1.2k 2.6× 165 6.0k
Bernd H. Belohradsky Germany 38 2.4k 1.3× 1.0k 1.5× 740 1.2× 1.2k 2.1× 1.4k 3.0× 98 5.1k
Anthony Hayward United States 40 2.1k 1.2× 2.5k 3.7× 452 0.7× 701 1.2× 450 1.0× 155 5.3k
Dag Kvale Norway 33 1.5k 0.8× 859 1.3× 776 1.2× 325 0.6× 739 1.6× 101 3.7k
Miguel Aste-Amézaga United States 21 2.7k 1.5× 632 0.9× 371 0.6× 382 0.7× 661 1.4× 24 3.9k
M G Giudizi Italy 22 3.1k 1.7× 613 0.9× 322 0.5× 276 0.5× 402 0.9× 29 4.5k
O. Brad Spiller United Kingdom 36 939 0.5× 1.2k 1.7× 443 0.7× 335 0.6× 392 0.8× 121 3.1k

Countries citing papers authored by Martha M. Eibl

Since Specialization
Citations

This map shows the geographic impact of Martha M. Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha M. Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha M. Eibl more than expected).

Fields of papers citing papers by Martha M. Eibl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha M. Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha M. Eibl. The network helps show where Martha M. Eibl may publish in the future.

Co-authorship network of co-authors of Martha M. Eibl

This figure shows the co-authorship network connecting the top 25 collaborators of Martha M. Eibl. A scholar is included among the top collaborators of Martha M. Eibl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha M. Eibl. Martha M. Eibl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geier, Christoph B., Jocelyn R. Farmer, Zsófia Földvári, et al.. (2019). Vasculitis as a major morbidity factor in patients with hypomorphic RAG mutations. Journal of Allergy and Clinical Immunology. 143(2). AB116–AB116. 2 indexed citations
2.
3.
Geier, Christoph B., et al.. (2017). Terminal 14q32.33 deletion as a novel cause of agammaglobulinemia. Clinical Immunology. 183. 41–45. 3 indexed citations
4.
Geier, Christoph B., et al.. (2015). Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens. PLoS ONE. 10(7). e0133220–e0133220. 30 indexed citations
5.
Quinti, Isabella, Martha M. Eibl, Helen Chapel, et al.. (2014). Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe. Frontiers in Immunology. 5. 629–629. 68 indexed citations
6.
Fischer, Michael B., Beate M. Rüger, Alexander Becherer, et al.. (2007). The presence of MOMA‐2+ macrophages in the outer B cell zone and protection of the splenic micro‐architecture from LPS‐induced destruction depend on secreted IgM. European Journal of Immunology. 37(10). 2825–2833. 6 indexed citations
7.
Eibl, N, Hermann M. Wolf, Gottfried Fischer, et al.. (2003). Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cellular Immunology. 221(1). 15–26. 62 indexed citations
8.
Eibl, Martha M., Wolfgang R. Mayr, & G. J. Thorbecke. (2002). Epitope Recognition Since Landsteiner’s Discovery 100 Years Since the Discovery of Human Blood Groups. Springer eBooks. 1 indexed citations
9.
Rücker, Elke, et al.. (2002). Identification of Two Nuclear Import Signals in the α-Gene Product ICP22 of Herpes Simplex Virus 1. Virology. 295(2). 360–370. 22 indexed citations
10.
Sandberg, Kenneth, Anders Fasth, Angelika Berger, et al.. (2000). Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. The Journal of Pediatrics. 137(5). 623–628. 48 indexed citations
11.
Leibl, Heinz, et al.. (1999). Humoral and cellular immunity induced by antigens adjuvanted with colloidal iron hydroxide. Vaccine. 17(9-10). 1017–1023. 14 indexed citations
12.
Gorse, Geoffrey J., Thomas J. Matthews, Robert B. Belshe, et al.. (1998). Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. Vaccine. 16(5). 493–506. 20 indexed citations
13.
14.
Eibl, Martha M., et al.. (1993). CD3, CD8 Double-Positive Cells from HIV-1-Infected Chimpanzees Show Group-Specific Inhibition of HIV-1 Replication. AIDS Research and Human Retroviruses. 9(5). 405–413. 16 indexed citations
15.
Eibl, Martha M., Zaruhi Küpcü, Josef W. Mannhalter, Gerald Eder, & Z Schaff. (1992). Dual Tropism of HIV-1 IIIB for Chimpanzee Lymphocytes and Monocytes. AIDS Research and Human Retroviruses. 8(1). 69–75. 4 indexed citations
16.
Rosén, Harald, et al.. (1992). Determination of placental ferritin (PLF)‐positive lymphocytes in women in early stages of breast cancer. International Journal of Cancer. 52(2). 229–233. 6 indexed citations
17.
Mannhalter, Josef W., Zaruhi Küpcü, N Barrett, et al.. (1991). Immunization of Chimpanzees with the HIV-1 Glycoprotein gp160 Induces Long-Lasting T-Cell Memory. AIDS Research and Human Retroviruses. 7(5). 485–493. 14 indexed citations
18.
Wolf, Hermann M. & Martha M. Eibl. (1991). The Relevance of Immunoglobulin in the Prevention of Necrotizing Enterocolitis. Advances in experimental medicine and biology. 310. 381–389. 6 indexed citations
19.
Zielinski, C. C., P. Sevelda, E. Kubista, et al.. (1988). Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunology Immunotherapy. 27(3). 278–82. 21 indexed citations
20.
Ahmad, Rafi, et al.. (1982). Plaque-Forming Cells in Human Cord Blood: A Soluble Factor Suppressing Differentiation but Not Proliferation of B Cells. International Archives of Allergy and Immunology. 69(2). 132–136. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Becky Adkins Breakdown of academic impact, for papers by Steve Kohl Breakdown of academic impact, for papers by E. Richard Stiehm Breakdown of academic impact, for papers by Raffaele Badolato Breakdown of academic impact, for papers by Bernd H. Belohradsky Breakdown of academic impact, for papers by Anthony Hayward Breakdown of academic impact, for papers by Dag Kvale Breakdown of academic impact, for papers by Miguel Aste-Amézaga Breakdown of academic impact, for papers by M G Giudizi Breakdown of academic impact, for papers by O. Brad Spiller
Rankless by CCL
2026